Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saud A Sadiq

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Biomarkers of multiple sclerosis: current findingsViolaine K Harris, John F Tuddenham, Saud A Sadiq
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosisFozia Mir, Donald Lee, Hetal Ray, et al.
Journal of Neurology|June 10, 2010
Intrathecal methotrexate treatment in multiple sclerosisSaud A Sadiq, Elena V Simon, Lauren M Puccio
Journal of Neurology|January 7, 2010
JCV detection in multiple sclerosis patients treated with natalizumabSaud A Sadiq, Lauren M Puccio, Edward W A Brydon
Stem Cells Translational Medicine|December 1, 2012
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosisViolaine K Harris, Raihan Faroqui, Tamara Vyshkina, et al.
Frontiers in Cellular Neuroscience|April 9, 2026
Impaired myelination in multiple sclerosis organoids: p21 links oligodendrocyte dysfunction to disease subtypeSaud A Sadiq, Tanmay Mehta, William Holzman, et al.
Immunity, Inflammation and Disease|October 14, 2017
Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathwayYing Liu, Marwan Alahiri, Bianca Ulloa, et al.
Therapeutic Advances in Neurological Disorders|December 14, 2019
Safety of long-term intrathecal methotrexate in progressive forms of MSJames W Stark, Lena Josephs, Deirdre Dulak, et al.
Journal of Neuroimmunology|June 27, 2013
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumabJerry Lin, Peggy Bettin, John K Lee, et al.
Plos One|August 11, 2023
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosisViolaine K Harris, Jaina Wollowitz, Jacelyn Greenwald, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Biomarkers of multiple sclerosis: current findingsViolaine K Harris, John F Tuddenham, Saud A Sadiq
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosisFozia Mir, Donald Lee, Hetal Ray, et al.
Journal of Neurology|June 10, 2010
Intrathecal methotrexate treatment in multiple sclerosisSaud A Sadiq, Elena V Simon, Lauren M Puccio
Journal of Neurology|January 7, 2010
JCV detection in multiple sclerosis patients treated with natalizumabSaud A Sadiq, Lauren M Puccio, Edward W A Brydon
Stem Cells Translational Medicine|December 1, 2012
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosisViolaine K Harris, Raihan Faroqui, Tamara Vyshkina, et al.
Frontiers in Cellular Neuroscience|April 9, 2026
Impaired myelination in multiple sclerosis organoids: p21 links oligodendrocyte dysfunction to disease subtypeSaud A Sadiq, Tanmay Mehta, William Holzman, et al.
Immunity, Inflammation and Disease|October 14, 2017
Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathwayYing Liu, Marwan Alahiri, Bianca Ulloa, et al.
Therapeutic Advances in Neurological Disorders|December 14, 2019
Safety of long-term intrathecal methotrexate in progressive forms of MSJames W Stark, Lena Josephs, Deirdre Dulak, et al.
Journal of Neuroimmunology|June 27, 2013
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumabJerry Lin, Peggy Bettin, John K Lee, et al.
Plos One|August 11, 2023
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosisViolaine K Harris, Jaina Wollowitz, Jacelyn Greenwald, et al.
Pageof 4